These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32982158)

  • 61. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
    J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Optical Coherence Tomography Predictors of Favorable Functional Response in Naïve Diabetic Macular Edema Eyes Treated with Dexamethasone Implants as a First-Line Agent.
    Meduri A; Oliverio GW; Trombetta L; Giordano M; Inferrera L; Trombetta CJ
    J Ophthalmol; 2021; 2021():6639418. PubMed ID: 33833870
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intravitreal Injection of Ozurdex(®) Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up.
    Pacella F; Ferraresi AF; Turchetti P; Lenzi T; Giustolisi R; Bottone A; Fameli V; Romano MR; Pacella E
    Ophthalmol Eye Dis; 2016; 8():11-6. PubMed ID: 27147895
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes.
    Zarranz-Ventura J; Romero-Núñez B; Bernal-Morales C; Velazquez-Villoria D; Sala-Puigdollers A; Figueras-Roca M; Copete S; Distefano L; Boixadera A; García-Arumi J; Adan A;
    BMC Ophthalmol; 2020 Nov; 20(1):443. PubMed ID: 33176749
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.
    Rodrigues MW; Cardillo JA; Messias A; Siqueira RC; Scott IU; Jorge R
    Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):479-490. PubMed ID: 31873786
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema.
    Mastropasqua R; Toto L; Borrelli E; Di Antonio L; De Nicola C; Mastrocola A; Di Nicola M; Carpineto P
    PLoS One; 2015; 10(12):e0145663. PubMed ID: 26720268
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intravitreal dexamethasone implant in naïve and previously treated patients with diabetic macular edema: a retrospective study.
    Medina-Baena M; Cejudo-Corbalán O; García-Pulido JI; Huertos-Carrillo MJ; Girela-López E
    Int J Ophthalmol; 2020; 13(10):1597-1605. PubMed ID: 33078111
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema.
    Kim KT; Jang JW; Kang SW; Chae JB; Cho K; Bae K
    Korean J Ophthalmol; 2019 Jun; 33(3):249-258. PubMed ID: 31179656
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases.
    Ou WC; Brown DM; Payne JF; Wykoff CC
    Am J Ophthalmol; 2017 Aug; 180():8-17. PubMed ID: 28549848
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema After Dexamethasone Implants.
    Huang YT; Chang YC; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Bair H; Lin JM; Chen WL; Tsai YY
    Front Med (Lausanne); 2022; 9():852022. PubMed ID: 35755055
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors.
    Tservakis I; Koutsandrea C; Papaconstantinou D; Paraskevopoulos T; Georgalas I
    Curr Drug Saf; 2015; 10(2):145-51. PubMed ID: 25092480
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intravitreal dexamethasone implant Ozurdex in the treatment of diabetic macular edema in patients not previously treated with any intravitreal drug: a prospective 12-month follow-up study.
    Menezo M; Roca M; Menezo V; Pascual I
    Curr Med Res Opin; 2019 Dec; 35(12):2111-2116. PubMed ID: 31378087
    [No Abstract]   [Full Text] [Related]  

  • 73. Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: A retrospective study of six cases.
    Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
    Therapie; 2016 Oct; 71(5):457-465. PubMed ID: 27203164
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea.
    Moon BG; Lee JY; Yu HG; Song JH; Park YH; Kim HW; Ji YS; Chang W; Lee JE; Oh J; Chung I
    J Ophthalmol; 2016; 2016():9810270. PubMed ID: 27293879
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of foveal photoreceptor layer in eyes with macular edema associated with branch retinal vein occlusion after ozurdex treatment.
    Altunel O; Duru N; Goktas A; Ozkose A; Goktas E; Atas M
    Int Ophthalmol; 2017 Apr; 37(2):333-339. PubMed ID: 27221365
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Results of dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema patients: Early versus late switch.
    Ruiz-Medrano J; Rodríguez-Leor R; Almazán E; Lugo F; Casado-Lopez E; Arias L; Ruiz-Moreno JM
    Eur J Ophthalmol; 2021 May; 31(3):1135-1145. PubMed ID: 32493065
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Short-term safety and efficacy of intravitreal 0.7-mg dexamethasone implants for pseudophakic cystoid macular edema.
    Al Zamil WM
    Saudi J Ophthalmol; 2015; 29(2):130-4. PubMed ID: 25892932
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Ranibizumab and aflibercept for diabetic macular edema-retrospective study with real-life data after 12 months].
    Holbach B; Zeman F; Helbig H; Gamulescu MA
    Ophthalmologe; 2020 Jul; 117(7):687-692. PubMed ID: 31705192
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis.
    Tsang AC; Virgili G; Abtahi M; Gottlieb CC
    Ocul Immunol Inflamm; 2017 Oct; 25(5):685-692. PubMed ID: 27191685
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intravitreal dexamethasone implant for macular edema secondary to retinal vein occlusion: 12-month follow-up and prognostic factors.
    Maggio E; Polito A; Guerriero M; Pertile G
    Ophthalmologica; 2014; 232(4):207-15. PubMed ID: 25471901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.